Suzanne K. Swan, MD; William M. Bennett, MD
Swan SK, Bennett WM. Oral Acyclovir and Neurotoxicity. Ann Intern Med. 1989;111:188. doi: 10.7326/0003-4819-111-2-188_1
Download citation file:
Published: Ann Intern Med. 1989;111(2):188.
To the Editor: Acyclovir (9- [ (2-hydroxyethoxy)methyl] guanine), an acyclic purine nuclease, is the treatment of choice for herpes zoster and varicella in the immunocompromised host. Adverse effects attributed to acyclovir therapy include nausea, vomiting, rash, phlebitis, myelosuppression, and decreased renal function. Neurotoxicity, manifested by vertigo, obtundation, headache, confusion, seizures, and tremor, has been linked to intravenous acyclovir therapy. To our knowledge, neurotoxicity has not been reported after oral acyclovir therapy. We present a case of neurotoxicity following orally administered acyclovir in a patient with end-stage renal disease.
A 76-year-old woman receiving chronic hemodialysis presented with a 2-day history of
Learn more about subscription options.
Register Now for a free account.
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only